|
NOL9 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.956800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.885200E-01 |
| Normal-vs-Stage2 |
4.808600E-01 |
| Normal-vs-Stage3 |
3.932400E-02 |
| Normal-vs-Stage4 |
7.895700E-03 |
| Stage1-vs-Stage2 |
2.600400E-01 |
| Stage1-vs-Stage3 |
6.284100E-03 |
| Stage1-vs-Stage4 |
1.439940E-03 |
| Stage2-vs-Stage3 |
4.099800E-01 |
| Stage2-vs-Stage4 |
1.680750E-01 |
| Stage3-vs-Stage4 |
4.508400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.902000E-01 |
| Normal-vs-AfricanAmerican |
9.332000E-02 |
| Normal-vs-Asian |
1.756820E-01 |
| Caucasian-vs-AfricanAmerican |
2.491200E-01 |
| Caucasian-vs-Asian |
5.524000E-02 |
| AfricanAmerican-vs-Asian |
2.776000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.594100E-02 |
| Normal-vs-Female |
6.757600E-01 |
| Male-vs-Female |
1.644390E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.033600E-02 |
| Normal-vs-Age(41-60Yrs) |
8.082800E-01 |
| Normal-vs-Age(61-80Yrs) |
2.378400E-01 |
| Normal-vs-Age(81-100Yrs) |
1.331000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.207800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.341600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.098000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.972400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.556760E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.103000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.697810E-03 |
| Normal-vs-Grade 2 |
3.472200E-01 |
| Normal-vs-Grade 3 |
1.568100E-02 |
| Normal-vs-Grade 4 |
6.861000E-03 |
| Grade 1-vs-Grade 2 |
4.926200E-02 |
| Grade 1-vs-Grade 3 |
3.629200E-04 |
| Grade 1-vs-Grade 4 |
1.581570E-04 |
| Grade 2-vs-Grade 3 |
2.767700E-04 |
| Grade 2-vs-Grade 4 |
7.625700E-04 |
| Grade 3-vs-Grade 4 |
3.807800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.283800E-02 |
| Normal-vs-ccB subtype |
1.027500E-02 |
| ccA subtype-vs-ccB subtype |
5.11480000020548E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.896200E-01 |
| Normal-vs-N1 |
1.026440E-01 |
| N0-vs-N1 |
3.077600E-01 |
|
|
